Wearable tech may transform blood pressure care for dialysis patients
NCT ID NCT07762859
First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time
Summary
This trial tests whether using a wearable cuffless blood pressure monitor to guide treatment can help more hemodialysis patients achieve target blood pressure than standard office-based measurements. Adults on maintenance hemodialysis with high blood pressure will be randomly assigned to either wearable-guided or office-guided management. The study will compare the proportion of patients reaching blood pressure goals and assess changes in blood pressure, medication use, and safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- CART BP Pro cuffless wearable blood pressure monitoring device
- What this could lead to
- If successful, this approach could lead to better blood pressure control and potentially reduce heart risks in hemodialysis patients.
- What could go wrong
- The device is new and may not be accurate in all patients. The trial is relatively small and results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESRD ON HD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gangnam Severance Hospital
Seoul, 06273, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.